McKesson Corp (MCK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH737D
- Pages: 72
- October 2018
- Total Views:1128
- Region : North America
- GlobalData
- Equity Research Report
Details
Summary
McKesson Corp (McKesson) is a provider of healthcare services and information technology solutions. It distributes pharmaceuticals, medical equipment, and health and beauty care products in North America and overseas. The company also develops and provides decision support software and systems to assist clinicians and physicians in clinical diagnosis and treatment. McKesson offers medicines, pharmaceutical solutions, information and care management products and services to pharmacies and institutional providers including hospitals and health systems. It also offers products and services to the alternative site market such as physician offices, surgery centers, long-term care facilities and home care businesses. It has operations in various countries including the US, the UK, Canada, Barbados, Bermuda, Germany, and Ireland. McKesson is headquartered in California, the US.
McKesson Corp (MCK)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
McKesson Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
McKesson Corp, Medical Devices Deals, 2012 to YTD 2018 10
McKesson Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
McKesson Corp, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Sanova Pharma to Acquire Okopharm, Okomed and BasoVital Products from Okopharm 13
Lloyds Pharmacy to Acquire Pharmacy Business from J Sainsbury for USD194.7 Million 14
Private Equity 15
New Mountain Capital Acquires Medical Specialties Distributors From Water Street Healthcare Partners 15
Penta Investments Receives Regulatory Approval To Acquire Lekarny Lloyds And Gehe Pharma From Celesio For USD 104 Million 16
Partnerships 18
Novocure Enters into Agreement with US Oncology Research 18
Epizyme Enters into Partnership with US Oncology Research 19
Genocea Biosciences Enters into Agreement with US Oncology Research 20
BTG International Enters into Agreement with Biologics 21
McKesson Specialty Health Collaborates with Oncologists to Develop New Oncology-Specific iKnowMed Generation 2 22
ValueOptions Enters Into Agreement With McKesson 23
Pfizer Enters Into Co-Marketing Agreement With Biologics For Inlyta 24
Debt Offering 25
Celesio Completes Private Placement Of Bonds Due 2016 For USD 453 Million 25
Acquisition 26
McKesson Acquires Vantage Oncology and Biologics for USD1.2 Billion 26
Cintas to Acquire ZEE Medical from McKesson for USD130 Million 28
Celesio Acquires Remaining 40% Stake in Oncoprod 29
McKesson Completes Acquisition Of Celesio For USD 8.49 Billion 30
Elliott Management Acquires Additional Stake In Celesio 32
McKesson Acquires Med3000, Provider Of Healthcare Management Services 33
Franz Haniel Sells 4.6% Stake In Celesio For USD 129.6 Million 34
McKesson To Acquire Emendo, Healthcare IT Company 35
Zur Rose Acquires DocMorris From Celesio For USD 32.4 Million 36
Owens & Minor Completes Acquisition Of Movianto From Celesio For USD 158 Million 37
Celesio Completes Acquisition Of Remaining 49.9% Stake In Panpharma For USD 341 Million 38
McKesson Acquires Provider Of Medical Imaging Work-flow Solutions, peerVue 39
McKesson Corp-Key Competitors 40
McKesson Corp-Key Employees 41
McKesson Corp-Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Recent Developments 46
Financial Announcements 46
Jul 26, 2018: McKesson Reports Fiscal 2019 First-Quarter Results 46
Jun 28, 2018: McKesson Reaffirms Fiscal 2019 Guidance and Provides Preliminary Guidance for the First Quarter 48
May 24, 2018: McKesson Reports Fiscal 2018 Fourth-Quarter and Full-Year Results 49
Jul 27, 2017: McKesson reports lower Q1 net income, updates outlook for fiscal 2018 52
Corporate Communications 53
Jul 31, 2018: McKesson Appoints Brian Tyler as President and Chief Operating Officer 53
Jul 09, 2018: The US Oncology Network Welcomes Breast Surgeon Dr. Loren Rourke to a New Role as Chief Surgical Officer 54
Legal and Regulatory 55
Aug 15, 2017: City of Birmingham and Legal Counsel Baron & Budd, Greene Ketchum, Levin Papantonio File Suit Against Pharmaceutical Distributors for Role in Creating Opioid Crisis 55
Government and Public Interest 56
Dec 04, 2017: McKesson RxO Team Identifies Five Health System Pharmacy Trends to Watch in 2018 56
Nov 02, 2017: US Oncology Research Annual Science Forum Focuses on Advances in Clinical Research, Enabling Promising New Treatments for Patients in the Community Setting 58
Product News 59
Apr 25, 2017: US Oncology Research Enrolls 2,900 Patients in Leading-Edge Clinical Trials in Twelve Months 59
Other Significant Developments 60
Sep 12, 2018: Health Mart launches National 'Power Your Partnerships' Series 60
Jul 11, 2018: McKesson ideaShare Exhibitors Donate to Nevada Childhood Cancer Foundation 61
Apr 04, 2018: McKesson Specialty Health And CoverMyMeds Launch ExpressCoverage, Integrated eServices Platform Designed To Improve Patient Care Journey 62
Mar 29, 2018: McKesson Announces New Initiatives, Launches Foundation to Help Fight Nation's Opioid Epidemic 63
Oct 31, 2017: McKesson Recommends Quick Federal Action on Key Opioid Solution Ideas 65
Oct 23, 2017: Health Mart and APCI Celebrate Pharmacists on Florida Independent Pharmacy Day 66
Feb 06, 2017: Value-based Care Services Provider, ACO Partner, Gains Traction in Arizona 67
Feb 02, 2017: McKesson Specialty Health and The US Oncology Network to Showcase Value-Based Care Expertise During Cancer Center Business Summit 69
Feb 01, 2017: Southern Cancer Center Joins The US Oncology Network 70
Jan 26, 2017: Vantage Oncology's 50 Centers and More Than 350 Affiliated Physicians Join The US Oncology Network 71
Appendix 72
Methodology 72
About GlobalData 72
Contact Us 72
Disclaimer 72
List Of Figure
List of Figures
McKesson Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
McKesson Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
McKesson Corp, Medical Devices Deals, 2012 to YTD 2018 10
List Of Table
List of Tables
McKesson Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
McKesson Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
McKesson Corp, Deals By Therapy Area, 2012 to YTD 2018 9
McKesson Corp, Medical Devices Deals, 2012 to YTD 2018 10
McKesson Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Sanova Pharma to Acquire Okopharm, Okomed and BasoVital Products from Okopharm 13
Lloyds Pharmacy to Acquire Pharmacy Business from J Sainsbury for USD194.7 Million 14
New Mountain Capital Acquires Medical Specialties Distributors From Water Street Healthcare Partners 15
Penta Investments Receives Regulatory Approval To Acquire Lekarny Lloyds And Gehe Pharma From Celesio For USD 104 Million 16
Novocure Enters into Agreement with US Oncology Research 18
Epizyme Enters into Partnership with US Oncology Research 19
Genocea Biosciences Enters into Agreement with US Oncology Research 20
BTG International Enters into Agreement with Biologics 21
McKesson Specialty Health Collaborates with Oncologists to Develop New Oncology-Specific iKnowMed Generation 2 22
ValueOptions Enters Into Agreement With McKesson 23
Pfizer Enters Into Co-Marketing Agreement With Biologics For Inlyta 24
Celesio Completes Private Placement Of Bonds Due 2016 For USD 453 Million 25
McKesson Acquires Vantage Oncology and Biologics for USD1.2 Billion 26
Cintas to Acquire ZEE Medical from McKesson for USD130 Million 28
Celesio Acquires Remaining 40% Stake in Oncoprod 29
McKesson Completes Acquisition Of Celesio For USD 8.49 Billion 30
Elliott Management Acquires Additional Stake In Celesio 32
McKesson Acquires Med3000, Provider Of Healthcare Management Services 33
Franz Haniel Sells 4.6% Stake In Celesio For USD 129.6 Million 34
McKesson To Acquire Emendo, Healthcare IT Company 35
Zur Rose Acquires DocMorris From Celesio For USD 32.4 Million 36
Owens & Minor Completes Acquisition Of Movianto From Celesio For USD 158 Million 37
Celesio Completes Acquisition Of Remaining 49.9% Stake In Panpharma For USD 341 Million 38
McKesson Acquires Provider Of Medical Imaging Work-flow Solutions, peerVue 39
McKesson Corp, Key Competitors 40
McKesson Corp, Key Employees 41
McKesson Corp, Other Locations 42
McKesson Corp, Subsidiaries 42
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
McKesson Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
McKesson Corp (McKesson) is a provider of healthcare services and information technology solutions. It distributes pharmaceuticals, medical equipment, and health and beauty care products in North America and overseas. The company also develops and provides decision support software and systems to assist clinicians and physicians in clinical diagnosis and treatment. McKesson offers medicines, pharmaceutical solutions, information and care management products and services to pharmacies and institutional providers including hospitals and health systems. It also offers products and services to the alternative site market such as physician offices, surgery centers, long-term care facilities and home care businesses. It has operations in various countries including the US, the UK, Canada, Barbados, Bermuda, Germany, and Ireland. McKesson is headquartered in California, the US.
McKesson Corp (MCK)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
McKesson Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
McKesson Corp, Medical Devices Deals, 2012 to YTD 2018 10
McKesson Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
McKesson Corp, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Sanova Pharma to Acquire Okopharm, Okomed and BasoVital Products from Okopharm 13
Lloyds Pharmacy to Acquire Pharmacy Business from J Sainsbury for USD194.7 Million 14
Private Equity 15
New Mountain Capital Acquires Medical Specialties Distributors From Water Street Healthcare Partners 15
Penta Investments Receives Regulatory Approval To Acquire Lekarny Lloyds And Gehe Pharma From Celesio For USD 104 Million 16
Partnerships 18
Novocure Enters into Agreement with US Oncology Research 18
Epizyme Enters into Partnership with US Oncology Research 19
Genocea Biosciences Enters into Agreement with US Oncology Research 20
BTG International Enters into Agreement with Biologics 21
McKesson Specialty Health Collaborates with Oncologists to Develop New Oncology-Specific iKnowMed Generation 2 22
ValueOptions Enters Into Agreement With McKesson 23
Pfizer Enters Into Co-Marketing Agreement With Biologics For Inlyta 24
Debt Offering 25
Celesio Completes Private Placement Of Bonds Due 2016 For USD 453 Million 25
Acquisition 26
McKesson Acquires Vantage Oncology and Biologics for USD1.2 Billion 26
Cintas to Acquire ZEE Medical from McKesson for USD130 Million 28
Celesio Acquires Remaining 40% Stake in Oncoprod 29
McKesson Completes Acquisition Of Celesio For USD 8.49 Billion 30
Elliott Management Acquires Additional Stake In Celesio 32
McKesson Acquires Med3000, Provider Of Healthcare Management Services 33
Franz Haniel Sells 4.6% Stake In Celesio For USD 129.6 Million 34
McKesson To Acquire Emendo, Healthcare IT Company 35
Zur Rose Acquires DocMorris From Celesio For USD 32.4 Million 36
Owens & Minor Completes Acquisition Of Movianto From Celesio For USD 158 Million 37
Celesio Completes Acquisition Of Remaining 49.9% Stake In Panpharma For USD 341 Million 38
McKesson Acquires Provider Of Medical Imaging Work-flow Solutions, peerVue 39
McKesson Corp-Key Competitors 40
McKesson Corp-Key Employees 41
McKesson Corp-Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Recent Developments 46
Financial Announcements 46
Jul 26, 2018: McKesson Reports Fiscal 2019 First-Quarter Results 46
Jun 28, 2018: McKesson Reaffirms Fiscal 2019 Guidance and Provides Preliminary Guidance for the First Quarter 48
May 24, 2018: McKesson Reports Fiscal 2018 Fourth-Quarter and Full-Year Results 49
Jul 27, 2017: McKesson reports lower Q1 net income, updates outlook for fiscal 2018 52
Corporate Communications 53
Jul 31, 2018: McKesson Appoints Brian Tyler as President and Chief Operating Officer 53
Jul 09, 2018: The US Oncology Network Welcomes Breast Surgeon Dr. Loren Rourke to a New Role as Chief Surgical Officer 54
Legal and Regulatory 55
Aug 15, 2017: City of Birmingham and Legal Counsel Baron & Budd, Greene Ketchum, Levin Papantonio File Suit Against Pharmaceutical Distributors for Role in Creating Opioid Crisis 55
Government and Public Interest 56
Dec 04, 2017: McKesson RxO Team Identifies Five Health System Pharmacy Trends to Watch in 2018 56
Nov 02, 2017: US Oncology Research Annual Science Forum Focuses on Advances in Clinical Research, Enabling Promising New Treatments for Patients in the Community Setting 58
Product News 59
Apr 25, 2017: US Oncology Research Enrolls 2,900 Patients in Leading-Edge Clinical Trials in Twelve Months 59
Other Significant Developments 60
Sep 12, 2018: Health Mart launches National 'Power Your Partnerships' Series 60
Jul 11, 2018: McKesson ideaShare Exhibitors Donate to Nevada Childhood Cancer Foundation 61
Apr 04, 2018: McKesson Specialty Health And CoverMyMeds Launch ExpressCoverage, Integrated eServices Platform Designed To Improve Patient Care Journey 62
Mar 29, 2018: McKesson Announces New Initiatives, Launches Foundation to Help Fight Nation's Opioid Epidemic 63
Oct 31, 2017: McKesson Recommends Quick Federal Action on Key Opioid Solution Ideas 65
Oct 23, 2017: Health Mart and APCI Celebrate Pharmacists on Florida Independent Pharmacy Day 66
Feb 06, 2017: Value-based Care Services Provider, ACO Partner, Gains Traction in Arizona 67
Feb 02, 2017: McKesson Specialty Health and The US Oncology Network to Showcase Value-Based Care Expertise During Cancer Center Business Summit 69
Feb 01, 2017: Southern Cancer Center Joins The US Oncology Network 70
Jan 26, 2017: Vantage Oncology's 50 Centers and More Than 350 Affiliated Physicians Join The US Oncology Network 71
Appendix 72
Methodology 72
About GlobalData 72
Contact Us 72
Disclaimer 72
List Of Figure
List of Figures
McKesson Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
McKesson Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
McKesson Corp, Medical Devices Deals, 2012 to YTD 2018 10
List Of Table
List of Tables
McKesson Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
McKesson Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
McKesson Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
McKesson Corp, Deals By Therapy Area, 2012 to YTD 2018 9
McKesson Corp, Medical Devices Deals, 2012 to YTD 2018 10
McKesson Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Sanova Pharma to Acquire Okopharm, Okomed and BasoVital Products from Okopharm 13
Lloyds Pharmacy to Acquire Pharmacy Business from J Sainsbury for USD194.7 Million 14
New Mountain Capital Acquires Medical Specialties Distributors From Water Street Healthcare Partners 15
Penta Investments Receives Regulatory Approval To Acquire Lekarny Lloyds And Gehe Pharma From Celesio For USD 104 Million 16
Novocure Enters into Agreement with US Oncology Research 18
Epizyme Enters into Partnership with US Oncology Research 19
Genocea Biosciences Enters into Agreement with US Oncology Research 20
BTG International Enters into Agreement with Biologics 21
McKesson Specialty Health Collaborates with Oncologists to Develop New Oncology-Specific iKnowMed Generation 2 22
ValueOptions Enters Into Agreement With McKesson 23
Pfizer Enters Into Co-Marketing Agreement With Biologics For Inlyta 24
Celesio Completes Private Placement Of Bonds Due 2016 For USD 453 Million 25
McKesson Acquires Vantage Oncology and Biologics for USD1.2 Billion 26
Cintas to Acquire ZEE Medical from McKesson for USD130 Million 28
Celesio Acquires Remaining 40% Stake in Oncoprod 29
McKesson Completes Acquisition Of Celesio For USD 8.49 Billion 30
Elliott Management Acquires Additional Stake In Celesio 32
McKesson Acquires Med3000, Provider Of Healthcare Management Services 33
Franz Haniel Sells 4.6% Stake In Celesio For USD 129.6 Million 34
McKesson To Acquire Emendo, Healthcare IT Company 35
Zur Rose Acquires DocMorris From Celesio For USD 32.4 Million 36
Owens & Minor Completes Acquisition Of Movianto From Celesio For USD 158 Million 37
Celesio Completes Acquisition Of Remaining 49.9% Stake In Panpharma For USD 341 Million 38
McKesson Acquires Provider Of Medical Imaging Work-flow Solutions, peerVue 39
McKesson Corp, Key Competitors 40
McKesson Corp, Key Employees 41
McKesson Corp, Other Locations 42
McKesson Corp, Subsidiaries 42
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
McKesson Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 130 | 
December 2020
Page 130 | December 2020
Page 131 | November 2020
Page 95 | November 2020
Page 96 | August 2020